Roxana Azimi

2.8k total citations
7 papers, 501 citations indexed

About

Roxana Azimi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Roxana Azimi has authored 7 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Roxana Azimi's work include Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Roxana Azimi is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Roxana Azimi collaborates with scholars based in United States, Sweden and France. Roxana Azimi's co-authors include Hira Rizvi, Giulia C. Leonardi, Jonathan W. Riess, Mark M. Awad, Matthew D. Hellmann, Justin F. Gainor, Sasha Kravets, Mehmet Altan, Suzanne E. Dahlberg and Lydia Gedmintas and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Plastic & Reconstructive Surgery Global Open.

In The Last Decade

Roxana Azimi

5 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxana Azimi United States	3	347	167	112	74	73	7	501
Liam Cornell United States	5	181 0.5×	210 1.3×	117 1.0×	73 1.0×	52 0.7×	7	414
Samuel Suzuki United States	9	228 0.7×	214 1.3×	130 1.2×	102 1.4×	39 0.5×	22	460
Giulia Orsi Italy	12	220 0.6×	171 1.0×	148 1.3×	113 1.5×	38 0.5×	34	514
Carla Castanaro United States	6	159 0.5×	245 1.5×	73 0.7×	100 1.4×	102 1.4×	9	434
T. Macarulla Mercadé Spain	12	296 0.9×	147 0.9×	128 1.1×	68 0.9×	57 0.8×	60	459
Maksim Yezhelyev Germany	7	183 0.5×	245 1.5×	61 0.5×	56 0.8×	48 0.7×	7	429
Peter Houghton United States	8	150 0.4×	171 1.0×	165 1.5×	76 1.0×	42 0.6×	20	400
Matthew R. Strickland United States	8	218 0.6×	251 1.5×	150 1.3×	74 1.0×	33 0.5×	18	475
Aaron J. Schueneman United States	7	183 0.5×	158 0.9×	109 1.0×	89 1.2×	39 0.5×	8	377
Catherine Copigneaux United States	9	259 0.7×	206 1.2×	109 1.0×	49 0.7×	78 1.1×	17	419

Countries citing papers authored by Roxana Azimi

Since Specialization

Citations

This map shows the geographic impact of Roxana Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Azimi more than expected).

Fields of papers citing papers by Roxana Azimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Azimi. The network helps show where Roxana Azimi may publish in the future.

Co-authorship network of co-authors of Roxana Azimi

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana Azimi. A scholar is included among the top collaborators of Roxana Azimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana Azimi. Roxana Azimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Azimi, Roxana, et al.. (2021). Eptifibatide-induced profound thrombocytopaenia: a rare complication. BMJ Case Reports. 14(6). e241594–e241594.

2.

Azimi, Roxana, et al.. (2021). Surgical Debulking of Persistent Orofacial Swelling in a Patient with Melkersson–Rosenthal Syndrome. Plastic & Reconstructive Surgery Global Open. 9(11). e3930–e3930.

3.

Leonardi, Giulia C., Justin F. Gainor, Mehmet Altan, et al.. (2018). Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders. Journal of Clinical Oncology. 36(19). 1905–1912. 258 indexed citations

4.

Tammela, Tuomas, Francisco J. Sánchez‐Rivera, Naniye Mallı Cetinbas, et al.. (2017). A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature. 545(7654). 355–359. 235 indexed citations

5.

Farago, Anna F., Martin S. Taylor, Robert C. Doebele, et al.. (2017). Clinicopathologic features of non-small cell lung cancer (NSCLC) harboring an NTRK gene fusion.. Journal of Clinical Oncology. 35(15_suppl). 11580–11580. 1 indexed citations

6.

Leonardi, Giulia C., Justin F. Gainor, Roxana Azimi, et al.. (2017). Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders.. Journal of Clinical Oncology. 35(15_suppl). 9081–9081. 6 indexed citations

7.

Azimi, Roxana. (2005). L’art et le marché. Commentaire. Numéro 110(2). 486–486. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact